Xylocaine 1% Inj, 20ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
In the event that you miss a dose, contact your doctor to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products.
- Report any unusual symptoms or discomfort during or after the procedure.
- Avoid touching or manipulating the numb area excessively to prevent injury until sensation returns.
Available Forms & Alternatives
Available Strengths:
- Xylocaine 4% Top Soln
- Xylocaine-Mpf 2% Inj, 10ml
- Xylocaine 2% Inj, 10ml
- Xylocaine-Mpf 1% Inj, 5ml
- Xylocaine 2% Inj, 20ml
- Xylocaine-Mpf 1% Inj, 30ml
- Xylocaine 2% Inj, 50ml
- Xylocaine-Mpf 0.5% Inj, 50ml
- Xylocaine-Mpf 1% Inj, 2ml
- Xylocaine-Mpf 2% Inj, 5ml
- Xylocaine 1% Inj, 20ml
- Xylocaine-Mpf 2% Inj, 2ml
- Xylocaine-Mpf 1% Inj, 10ml
- Xylocaine 1% Inj, 50ml
- Xylocaine 0.5% Inj, 50ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following signs or symptoms, contact your doctor or seek medical attention immediately:
Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Methemoglobinemia: A blue or gray color of the lips, nails, or skin, abnormal heartbeat, seizures, severe dizziness or fainting, severe headache, excessive sleepiness, feeling tired or weak, or shortness of breath. This rare condition can be life-threatening if left untreated.
Acidosis (Too Much Acid in the Blood): Confusion, rapid breathing, rapid heartbeat, abnormal heartbeat, severe stomach pain, nausea, vomiting, excessive sleepiness, shortness of breath, or feeling extremely tired or weak.
Respiratory Problems: Trouble breathing, slow breathing, or shallow breathing.
Central Nervous System Effects: Feeling lightheaded, sleepy, confused, or experiencing blurred vision.
Cardiovascular Effects: Slow heartbeat.
Neurological Effects: Feeling nervous and excitable, trouble speaking, burning, numbness, or tingling sensations, restlessness, anxiety, changes in vision, ringing in the ears, dizziness or fainting, severe headache, twitching, shakiness, seizures, feeling hot or cold, or metallic taste.
Cardiac Effects: Chest pain.
Mood Changes: Changes in mood.
Additional Side Effects (Injection into the Spine):
Sexual Dysfunction: Difficulty getting or maintaining an erection.
Motor Function: Loss of movement or control over stools and urine.
Urinary Problems: Trouble passing urine.
Other Side Effects
Not everyone experiences side effects, and many people have only minor side effects. However, if you notice any side effects that bother you or persist, contact your doctor for advice. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.
Reporting Side Effects
You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Feeling lightheaded or dizzy
- Ringing in your ears (tinnitus)
- Numbness or tingling around your mouth
- Unusual anxiety or nervousness
- Muscle twitching or tremors
- Blurred vision
- Difficulty breathing
- Slow or irregular heartbeat
Before Using This Medicine
To ensure safe treatment, inform your doctor about the following:
Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reactions you experienced.
If you are scheduled to receive this medication via spinal injection, tell your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site
It is crucial to disclose all your health conditions and medications to your doctor and pharmacist, including:
Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins
This will help determine if it is safe to take this medication with your existing health conditions and other drugs. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Risk of Methemoglobinemia
A severe blood disorder called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Heart problems
Lung problems
Are taking certain other medications
Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.
Sulfite Allergy
If you are allergic to sulfites, consult your doctor, as some products may contain sulfites.
Caution with Daily Activities
Avoid driving and performing tasks that require alertness until the effects of this medication have worn off and you feel fully awake.
Protecting the Treated Area
If you are discharged before the numbness has resolved, take precautions to protect the treated area from injury until you have regained sensation.
Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks with your doctor.
Injection (Spinal Administration)
This medication may cause temporary loss of sensation and motor function in the lower half of your body. Do not attempt to get out of bed or perform tasks until feeling and motor function have returned to normal.
Mouth and Dental Procedures
Do not eat while your mouth is numb, as you may inadvertently bite your tongue.
Overdose Information
Overdose Symptoms:
- Severe dizziness or lightheadedness
- Confusion or disorientation
- Slurred speech
- Seizures
- Loss of consciousness
- Slow heart rate (bradycardia)
- Low blood pressure (hypotension)
- Cardiac arrest
What to Do:
If you experience any of these severe symptoms, seek immediate medical attention. Call 911 or your local emergency number. For general overdose information, contact a poison control center at 1-800-222-1222.
Drug Interactions
Contraindicated Interactions
- Known hypersensitivity to amide-type local anesthetics
- Stokes-Adams syndrome
- Severe degrees of heart block (e.g., second or third-degree AV block) without a pacemaker (when used as antiarrhythmic, but caution for local use if systemic absorption is high)
Major Interactions
- Antiarrhythmics (Class I, e.g., mexiletine, procainamide): Additive cardiac effects, increased risk of toxicity.
- Beta-blockers (e.g., propranolol, metoprolol): May decrease hepatic clearance of lidocaine, increasing plasma levels and risk of toxicity.
- Cimetidine: May inhibit lidocaine metabolism, increasing plasma levels and risk of toxicity.
Moderate Interactions
- Succinylcholine: May prolong neuromuscular blockade.
- Phenytoin: May increase lidocaine metabolism (less common interaction).
- MAOIs, TCAs, phenothiazines (if lidocaine contains epinephrine): May cause severe prolonged hypertension or arrhythmias.
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To identify hypersensitivity to amide-type local anesthetics.
Timing: Prior to administration
Rationale: To establish baseline and detect early signs of systemic toxicity.
Timing: Prior to administration
Rationale: To assess risk factors for toxicity (e.g., cardiac, hepatic impairment).
Timing: Prior to administration
Routine Monitoring
Frequency: During and immediately after administration, then as clinically indicated.
Target: Within patient's normal range
Action Threshold: Significant deviations (e.g., bradycardia, hypotension, respiratory depression) warrant immediate intervention.
Frequency: During and immediately after administration, then as clinically indicated.
Target: Alert and oriented, no abnormal neurological signs
Action Threshold: Signs of CNS toxicity (e.g., circumoral numbness, tinnitus, dizziness, agitation, muscle twitching, seizures) require immediate intervention.
Frequency: Continuous during administration of large doses or in patients with cardiac disease.
Target: Normal sinus rhythm, no conduction abnormalities
Action Threshold: Arrhythmias, conduction delays (e.g., QRS widening), or bradycardia require immediate intervention.
Symptom Monitoring
- Lightheadedness
- Dizziness
- Tinnitus (ringing in ears)
- Perioral numbness or tingling
- Metallic taste
- Blurred vision
- Tremors or muscle twitching
- Nervousness or anxiety
- Drowsiness or sedation
- Slurred speech
- Seizures
- Bradycardia
- Hypotension
- Cardiac arrest
Special Patient Groups
Pregnancy
Lidocaine is generally considered safe for use as a local anesthetic during pregnancy (Pregnancy Category B). It crosses the placenta but is rapidly metabolized. Use the lowest effective dose.
Trimester-Specific Risks:
Lactation
Lidocaine is excreted into breast milk in small amounts. The amount transferred to the infant is generally considered too small to cause adverse effects. It is rated L2 (likely compatible) by LactMed. Use the lowest effective dose.
Pediatric Use
Pediatric patients, especially infants and young children, are more susceptible to systemic toxicity due to differences in metabolism, distribution, and higher relative doses per body weight. Dosing must be carefully calculated based on weight (mg/kg) and the lowest effective concentration and volume should be used. Close monitoring for signs of systemic toxicity is crucial.
Geriatric Use
Elderly patients may have reduced hepatic blood flow and metabolism, leading to higher plasma concentrations and increased risk of systemic toxicity. Lower doses may be required, and careful monitoring for adverse effects is recommended. Co-morbidities (e.g., cardiac, renal impairment) should be considered.
Clinical Information
Clinical Pearls
- Always aspirate prior to injection to ensure the needle is not in a blood vessel, which can lead to rapid systemic absorption and toxicity.
- Use the lowest effective concentration and volume to achieve the desired anesthetic effect.
- The addition of epinephrine (vasoconstrictor) prolongs the duration of action and reduces systemic absorption, but should be avoided in areas with end-arterial circulation (e.g., fingers, toes, nose, penis, ears) due to risk of ischemia.
- Be vigilant for signs of Local Anesthetic Systemic Toxicity (LAST), which can manifest as CNS symptoms (e.g., circumoral numbness, tinnitus, seizures) or cardiovascular symptoms (e.g., bradycardia, hypotension, arrhythmias). Lipid emulsion therapy is the antidote for severe LAST.
- Patients with cardiac conduction abnormalities (e.g., sick sinus syndrome, severe AV block) are at higher risk for cardiac adverse effects if systemic absorption occurs.
Alternative Therapies
- Bupivacaine (longer duration of action)
- Ropivacaine (less cardiotoxic than bupivacaine)
- Mepivacaine (similar to lidocaine, slightly longer duration)
- Prilocaine (less cardiotoxic, but risk of methemoglobinemia with high doses)
- Chloroprocaine (ester-type, very short duration, rapid metabolism)
- Topical anesthetics (e.g., benzocaine, tetracaine)
- Cryoanalgesia
- Non-pharmacological pain management techniques